Dr. Chase Cornelison is currently an Assistant Professor of Biomedical Engineering at the University of Massachusetts Amherst. He received his B.S. from the University of Tennessee, Knoxville and his PhD from the University of Texas at Austin, both in Chemical Engineering. His graduate work focused on biomaterials for spinal cord regeneration, and his postdoctoral work focused on the role of the tumor microenvironment in brain cancer progression and therapy. Currently, the Cornelison Group conducts research at the intersection of biomaterials, neuroscience, and cancer to better understand the process of traumatic neurodegeneration and develop new biomaterial strategies for neuroregeneration. The group has received federal funding for their current work in this area. Dr. Cornelison is a member of professional societies such as the Biomedical Engineering Society (BMES) and Society for Biomaterials (SFB).
Dr. Chase Cornelison is currently an Assistant Professor of Biomedical Engineering at the University of Massachusetts Amherst. He received his B.S. from the University of Tennessee, Knoxville and his PhD from the University of Texas at Austin, both in Chemical Engineering. His graduate work focused on biomaterials for spinal cord regeneration, and his postdoctoral work focused on the role of the tumor microenvironment in brain cancer progression and therapy. Currently, the Cornelison Group conducts research at the intersection of biomaterials, neuroscience, and cancer to better understand the process of traumatic neurodegeneration and develop new biomaterial strategies for neuroregeneration. The group has received federal funding for their current work in this area. Dr. Cornelison is a member of professional societies such as the Biomedical Engineering Society (BMES) and Society for Biomaterials (SFB).